Learning Study: Improving Vision in Adults With Macular Degeneration
Macular Degeneration
About this trial
This is an interventional treatment trial for Macular Degeneration focused on measuring Macular Degeneration, Brain Stimulation, Psychophysics, Reading, tDCS, RSVP, Visual Acuity, Uncrowded Visual Acuity, Crowded Visual Acuity, Contrast Sensitivity
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of AMD (age 60+) or JMD (current age 18+).
- Visual acuity (VA); between 6/9-6/96 in the better eye
- Best-corrected near visual acuity of 4.0M at 40 cm or better in the better eye
- Stable vision in previous 3 months (patient report)
- Central vision loss
Exclusion Criteria:
- Diagnosed dementia.
- Not fluent in reading English (Waterloo) or Chinese characters (Hong Kong).
- Any ocular surgery (including anti-vegF injections) within the duration of the study, except for: A. Chronic and continuous injections for at least 1 year. B. Injections stopped at least 2 months before participation. C. Injections in the untested eye
- Ocular pathology other than JMD or AMD that can significantly reduce central vision. Example: mild cataract of grade 2 or below is acceptable
- Severe hearing impairment.
- Contraindications for brain stimulation
Sites / Locations
- University of Waterloo
- The Hong Kong Polytechnic UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Active + Training
Sham + Training
Participants in this arm will be exposed to active stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.
Participants in this arm will be exposed to sham stimulation for the first 25 minutes of a roughly hour - long perceptual training procedure in which participants must verbally read sentences presented at various speeds and sizes.